Royalty Pharma plc (RPRX)
Pharmaceutical Preparations · Healthcare · $30.2B
Intrinsic Value (Consensus)
$33.47
Current Price
$54.21
Margin of Safety
-38.3%
38.3% Above Intrinsic Value
Value: $33
Price: $54
Valuation Model Estimates
Current Price: $54.21
DCF (Discounted Cash Flow)
$47.54
Graham Number
Not applicable
—
Earnings Power Value
$17.28
Relative Value (P/E)
$35.60
Dividend Discount Model
Not applicable
—
Consensus Value
$33.47
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
44
Profitability
10/25
Strength
17/25
Valuation
7/25
Growth
10/25
Key Financials
- EPS (TTM)
- $1.78
- EPS (Forward)
- $1.82
- Book Value
- —
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 5.1%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance